Chronic pain clinical trials in Laval
4
Trials
0
Recruiting or not yet
4
Trial sites
Trials with a site in Laval
4 trials, recruiting first
| Phase | ||||
|---|---|---|---|---|
| A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy NCT01041859 | Completed | Phase 3 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-12 |
| Safety and Efficacy of AEG33773 Versus Placebo in Patients With Painful Diabetic Peripheral Neuropathy NCT00891683 | Completed | Phase 2 | Aegera Therapeutics | 2009-03 |
| [S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy. NCT00348894 | Terminated | Phase 2 | Pfizer | 2006-07 |
| Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia NCT00313885 | Completed | Phase 2 | Sanofi | 2004-04 |
Facilities listed in the registry
- Sanofi-Aventis Administrative Office (1 trial site)
- Pfizer Investigational Site (1 trial site)
- Centre de Recherche Clinique de Laval (1 trial site)
Facility names are as entered by study registrants. This is not a clinic directory.
Map
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.